Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Steroids. 2011 May 8;76(9):910–920. doi: 10.1016/j.steroids.2011.04.015

Fig. 5. Expression of progesterone receptor (PR) in human NSCLC cell lines.

Fig. 5

Significant immunoreactivity for PR-A and PR-B was detected in NSCLC cancer cell lines and in control human breast cancer cell line MCF-7. Western blots were performed as described in methods. GAPDH is shown as a loading control.